Showing results (41-50 of 92) with videos related to
Sort By:
Pageof 10
The Medical Journal of Australia|February 5, 1996
Consumption of oily fish and childhood asthma riskL Hodge, C M Salome, J K Peat, et al.Journal of Cellular Biochemistry|April 1, 1995
Site-directed mutagenesis of the arginine-glycine-aspartic acid sequence in osteopontin destroys cell adhesion and migration functionsJ W Xuan, C Hota, Y Shigeyama, et al.The Journal of Urology|October 12, 2000
PSP94 expression after androgen deprivation therapy: a comparative study with prostate specific antigen in benign prostate and prostate cancerY Imasato, J W Xuan, H Sakai, et al.Oncogene|January 28, 2005
Knockin of SV40 Tag oncogene in a mouse adenocarcinoma of the prostate model demonstrates advantageous features over the transgenic modelWenming Duan, Manal Y Gabril, Madeleine Moussa, et al.Oncogene|September 21, 1995
Alternative splicing of PSP94 (prostatic secretory protein of 94 amino acids) mRNA in prostate tissueJ W Xuan, J L Chin, Y Guo, et al.Journal of Medical Economics|May 26, 2016
Modeling the cost-effectiveness of ilaprazole versus omeprazole for the treatment of newly diagnosed duodenal ulcer patients in ChinaJ W Xuan, R L Song, G X Xu, et al.The Prostate|September 9, 1999
In situ hybridization study of PSP94 (prostatic secretory protein of 94 amino acids) expression in human prostatesP S Chan, L W Chan, J W Xuan, et al.The American Journal of Physiology|December 9, 1998
Osteopontin inhibits inducible nitric oxide synthase activity in rat vascular tissueJ A Scott, M L Weir, S M Wilson, et al.Thorax|February 6, 2002
Risk factors for onset and remission of atopy, wheeze, and airway hyperresponsivenessW Xuan, G B Marks, B G Toelle, et al.Zhonghua Yi Xue Za Zhi|March 21, 2017
[Cost-effectiveness analysis of octreotide long acting release and lanreotide slow release for the treatment of postoperative patients with active acromegaly in China]J W Xuan, Z Y Zhang, Y F Wang, et al.Pageof 10